BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18223694)

  • 41. HSP90 affects the stability of BMAL1 and circadian gene expression.
    Schneider R; Linka RM; Reinke H
    J Biol Rhythms; 2014 Apr; 29(2):87-96. PubMed ID: 24682203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90) in vitro.
    Morales JL; Perdew GH
    Biochemistry; 2007 Jan; 46(2):610-21. PubMed ID: 17209571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CHIP-dependent p53 regulation occurs specifically during cellular senescence.
    Sisoula C; Trachana V; Patterson C; Gonos ES
    Free Radic Biol Med; 2011 Jan; 50(1):157-65. PubMed ID: 20974249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system.
    Stahl M; Retzlaff M; Nassal M; Beck J
    Nucleic Acids Res; 2007; 35(18):6124-36. PubMed ID: 17804463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling.
    Germano S; Barberis D; Santoro MM; Penengo L; Citri A; Yarden Y; Gaudino G
    J Biol Chem; 2006 Aug; 281(31):21710-21719. PubMed ID: 16740632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hsp90 is essential for restoring cellular functions of temperature-sensitive p53 mutant protein but not for stabilization and activation of wild-type p53: implications for cancer therapy.
    Müller P; Ceskova P; Vojtesek B
    J Biol Chem; 2005 Feb; 280(8):6682-91. PubMed ID: 15613472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification and assay of the chaperone-dependent ubiquitin ligase of the carboxyl terminus of Hsc70-interacting protein.
    Murata S; Minami M; Minami Y
    Methods Enzymol; 2005; 398():271-9. PubMed ID: 16275335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ubiquitination and degradation of mutant p53.
    Lukashchuk N; Vousden KH
    Mol Cell Biol; 2007 Dec; 27(23):8284-95. PubMed ID: 17908790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proposal for a role of the Hsp90/Hsp70-based chaperone machinery in making triage decisions when proteins undergo oxidative and toxic damage.
    Pratt WB; Morishima Y; Peng HM; Osawa Y
    Exp Biol Med (Maywood); 2010 Mar; 235(3):278-89. PubMed ID: 20404045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. UBR1 promotes protein kinase quality control and sensitizes cells to Hsp90 inhibition.
    Sultana R; Theodoraki MA; Caplan AJ
    Exp Cell Res; 2012 Jan; 318(1):53-60. PubMed ID: 21983172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hsp70 and Hsp90 multichaperone complexes sequentially regulate thiazide-sensitive cotransporter endoplasmic reticulum-associated degradation and biogenesis.
    Donnelly BF; Needham PG; Snyder AC; Roy A; Khadem S; Brodsky JL; Subramanya AR
    J Biol Chem; 2013 May; 288(18):13124-35. PubMed ID: 23482560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and Proteomic Analysis of Ubiquitination of Hsc70 and Hsp70 by the E3 Ligase CHIP.
    Soss SE; Rose KL; Hill S; Jouan S; Chazin WJ
    PLoS One; 2015; 10(5):e0128240. PubMed ID: 26010904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions.
    Walerych D; Olszewski MB; Gutkowska M; Helwak A; Zylicz M; Zylicz A
    Oncogene; 2009 Dec; 28(48):4284-94. PubMed ID: 19749793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutant conformation of p53 translated in vitro or in vivo requires functional HSP90.
    Blagosklonny MV; Toretsky J; Bohen S; Neckers L
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8379-83. PubMed ID: 8710879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CHIP functions an E3 ubiquitin ligase of Runx1.
    Shang Y; Zhao X; Xu X; Xin H; Li X; Zhai Y; He D; Jia B; Chen W; Chang Z
    Biochem Biophys Res Commun; 2009 Aug; 386(1):242-6. PubMed ID: 19524548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes.
    Wang Y; McAlpine SR
    Chem Commun (Camb); 2015 Jan; 51(8):1410-3. PubMed ID: 25333923
    [TBL] [Abstract][Full Text] [Related]  

  • 57. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells.
    Samant RS; Clarke PA; Workman P
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6834-9. PubMed ID: 24760825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.
    Shimizu H; Saliba D; Wallace M; Finlan L; Langridge-Smith PR; Hupp TR
    Biochem J; 2006 Jul; 397(2):355-67. PubMed ID: 16579792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
    Selkirk JK; Merrick BA; Stackhouse BL; He C
    Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
    Huang Z; Nie L; Xu M; Sun XH
    Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.